Smith & Nephew (LON:SN) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Smith & Nephew plc (LON:SN)’s stock price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,068.92 ($13.96) and traded as high as GBX 1,127 ($14.72). Smith & Nephew shares last traded at GBX 1,120.50 ($14.63), with a volume of 2,614,359 shares changing hands.

Wall Street Analyst Weigh In

Separately, Berenberg Bank reaffirmed a “buy” rating and issued a £145 ($189.34) target price on shares of Smith & Nephew in a research report on Monday, August 5th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of GBX 3,956.20 ($51.66).

Smith & Nephew Trading Up 0.6 %

The business’s 50-day simple moving average is GBX 1,155.06 and its two-hundred day simple moving average is GBX 1,069.82. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The company has a market capitalization of £9.83 billion, a PE ratio of 4,175.93, a PEG ratio of 0.46 and a beta of 0.62.

Smith & Nephew Cuts Dividend

The business also recently declared a dividend, which will be paid on Friday, November 8th. Stockholders of record on Thursday, October 3rd will be given a dividend of $0.14 per share. This represents a dividend yield of 1%. The ex-dividend date is Thursday, October 3rd. Smith & Nephew’s payout ratio is currently 10,740.74%.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.